An Etiopathological Study of Vatarakta wsr to Gout and therapeutic effect(Upshayatmak Parikshan) of Anshumati Kwath
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- relief in sign and symptoms of vatarakta
研究概览
简要总结
Under this clinical study minimum 40 patients of vatarakta will be treated with Anshumati Kwatha . the constituents of this drugs are Shunthi, Pippali, Shalparni which have the properties of Deepan, Shoolaprashaman, Angamarda prashaman, Shothahar, Balya, Snehopag activities according to ayurvedic view. on the other hand that ingredients show Anti-inflammatory, Analgesic, Lubericating activity according to modern view.
Due to their above Properties this drug acts on remission of sign and symptoms of vatarakta. Period of trial will be of one month with seven days follow-up. patients will be selected from OPD and IPD and will be diagnosed on the basis of the sign and symptom along with laboratory investigation and radiological investigations., then assessment will be done and conclusion will be drawn after completion of study.
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 18.00 Year(s) 至 70.00 Year(s)（—）
- 性别
- All
入选标准
- •patients presenting with classical sign and symptoms of Vatarakta patients of Hyperuricemia with Gouty arthritis.
排除标准
- •patients associated with metabolic disorder and systemic disease patients of autoimmune joint disorder except RA.
结局指标
主要结局
relief in sign and symptoms of vatarakta
时间窗: 30 days
次要结局
- improve quality of life of patients suffering from vatarakta(45 days)